EGFR and non-small cell lung carcinoma: Conversely, EGFR is an oncogene that has been widely examined and whose activation, regardless of the pathway/mechanism, is a main culprit in lung tumor initiation, evidenced by its mutation being observable in 43%-89% of cases regarding NSCLC [45,46].